Andrea Faraci
Obstetrics & Gynecology · Hialeah, FLNPI 1033572334
Payments from drug & device makers
Across 98 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$451
- AbbVie$432
- Mayne Pharma Commercial LLC$377
- Organogenesis Inc.$265
- Millicent US Inc$89
- Hologic Sales And Service, LLC$88
- plus $475 from 12 others
What the payments were for
- Food & beverage$2,10397%
- Education$753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 22 | $451 |
| AbbVie | 28 | $432 |
| Mayne Pharma Commercial LLC | 10 | $377 |
| Organogenesis Inc. | 4 | $265 |
| Millicent US Inc | 4 | $89 |
| Hologic Sales And Service, LLC | 3 | $88 |
| Pfizer | 5 | $85 |
| Sumitomo Pharma America, Inc. | 3 | $59 |
| Coopersurgical, Inc. | 3 | $53 |
| Organon | 6 | $50 |
| Integra Lifesciences Corporation | 1 | $48 |
| Johnson & Johnson | 1 | $43 |
| Shield Therapeutics Inc | 2 | $34 |
| Exeltis, USA Inc. | 2 | $32 |
| Smith+Nephew | 1 | $24 |
| Therapeuticsmd, Inc. | 1 | $18 |
| Merck | 1 | $15 |
| Exact Sciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$237
- NEXTSTELLIS$122
How this compares
$2,178 in reported general payments places this provider in the 70th percentile of 2,438 obstetrics & gynecology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 15 | $6,791 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 17 | $319 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $309 |
| Fluconazole | 20 | $145 |
| Misoprostol | 16 | $30 |
| Diazepam | 11 | $10 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $85 | $6,79115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,438 obstetrics & gynecology providers in Florida.
Other obstetrics & gynecology in Hialeah
- Rafael Garcia-OcasioHialeah$2M
- Ramon HechavarriaHialeah$956K
- Hugo FerraraHialeah$409K
- Samuel LedermanLake Worth$13.4M
- Richard MyersJacksonville$2.7M
- Guillermo LievanoMiami$2.5M
- Steven McCarusCelebration$2.3M
- Samuel WolfPanama City$2.1M
- Douglas MoffettLeesburg$1.7M
- Harvey GlasserAventura$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.